← Eichor
Study identifier: NCT06094660 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

RFA or Chemical Neurolysis of the Genicular Nerves Compared to Conservative Treatment for Knee Pain Caused by OA

Condition: Osteo Arthritis Knee · Knee Pain Chronic  ·  Sponsor: Dijklander Ziekenhuis

PhaseNA
Planned participants192
Who can joinAll sexes, 35 Years to 90 Years
Healthy volunteersNo

About this study

A randomised controlled triall (RCT) with three parallel arms comparing the functional outcome of chemical ablation with phenol and radiofrequency ablation (RFA) of the genicular nerves with conservative treatment in patients with chronic knee pain caused by osteoarthritis (OA).

This description comes directly from the study's public registry record.

Talk to the study team

Gezina Oei, MD,PhD  ·  0031229257257  ·  g.t.m.l.oei@dijklander.nl

Aine Honohan, MSc  ·  0031646340596  ·  a.g.honohan@Dijklander.nl

Always discuss trial participation with your own doctor first.

Locations (2)

Dijklander ZiekenhuisHoorn, North Holland, NetherlandsRecruiting
Bravis ZiekenhuisRoosendaal, NetherlandsNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06094660